Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | acid phosphatase, putative | 0.0051 | 1 | 1 |
Trypanosoma cruzi | membrane-bound acid phosphatase 2, putative | 0.0049 | 0 | 0.5 |
Entamoeba histolytica | histidine acid phosphatase family protein | 0.0051 | 1 | 0.5 |
Trichomonas vaginalis | acid phosphatase, putative | 0.0051 | 1 | 1 |
Trichomonas vaginalis | Lysophosphatidic acid phosphatase type 6 precursor, putative | 0.0051 | 1 | 1 |
Trichomonas vaginalis | prostatic acid phosphatase, putative | 0.0051 | 1 | 1 |
Trypanosoma brucei | membrane-bound acid phosphatase 2 | 0.0049 | 0 | 0.5 |
Schistosoma mansoni | acid phosphatase-related | 0.0051 | 1 | 0.5 |
Entamoeba histolytica | histidine acid phosphatase family protein | 0.0051 | 1 | 0.5 |
Giardia lamblia | Lysosomal acid phosphatase precursor | 0.0051 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Leishmania major | membrane-bound acid phosphatase 2, putative | 0.0051 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 1 | 0.5 |
Trichomonas vaginalis | acid phosphatase, putative | 0.0051 | 1 | 1 |
Echinococcus granulosus | lysosomal acid phosphatase | 0.0051 | 1 | 1 |
Schistosoma mansoni | prostatic acid phosphatase | 0.0051 | 1 | 0.5 |
Trichomonas vaginalis | acid phosphatase, putative | 0.0051 | 1 | 1 |
Trypanosoma cruzi | membrane-bound acid phosphatase 2, putative | 0.0049 | 0 | 0.5 |
Onchocerca volvulus | 0.0051 | 1 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Trypanosoma cruzi | membrane-bound acid phosphatase 2, putative | 0.0049 | 0 | 0.5 |
Echinococcus multilocularis | lysosomal acid phosphatase | 0.0051 | 1 | 1 |
Trichomonas vaginalis | histidine acid phosphatase, putative | 0.0051 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Leishmania major | membrane-bound acid phosphatase 2 | 0.0051 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Trichomonas vaginalis | acid phosphatase, putative | 0.0051 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Trichomonas vaginalis | testicular acid phosphatase, putative | 0.0051 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Trichomonas vaginalis | acid phosphatase, putative | 0.0051 | 1 | 1 |
Trypanosoma brucei | membrane-bound acid phosphatase 1 precursor | 0.0049 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | 0 % | Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6 M; Not determined | ChEMBL. | 11934581 |
Inhibition (binding) | 0 % | Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-8 M; Not determined | ChEMBL. | 11934581 |
Inhibition (binding) | 0 % | Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-9 M; Not determined | ChEMBL. | 11934581 |
Inhibition (binding) | = 14.5 % | Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-7 M | ChEMBL. | 11934581 |
Inhibition (binding) | = 14.5 % | Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-7 M | ChEMBL. | 11934581 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.